Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA.
Expert Rev Mol Diagn. 2011 Jan;11(1):79-89. doi: 10.1586/erm.10.103.
miRNAs are small, endogenously expressed noncoding RNAs that regulate gene expression, mainly at the post-transcriptional level, via degradation or translational inhibition of their target mRNAs. Functionally, an individual miRNA can regulate the expression of multiple target genes. The study of miRNAs is rapidly growing and recent studies have revealed a significant role of miRNAs in vascular biology and disease. Many miRNAs are highly expressed in the vasculature, and their expression is dysregulated in diseased vessels. Several miRNAs have been found to be critical modulators of vascular pathologies, such as atherosclerosis, lipoprotein metabolism, inflammation, arterial remodeling, angiogenesis, smooth muscle cell regeneration, hypertension, apoptosis, neointimal hyperplasia and signal transduction pathways. Thus, miRNAs may serve as novel biomarkers and/or therapeutic targets for vascular disease. This article summarizes the current studies related to the disease correlations and functional roles of miRNAs in the vascular system and discusses the potential applications of miRNAs in vascular disease.
miRNAs 是小的、内源性表达的非编码 RNA,主要通过降解或翻译抑制其靶 mRNAs 来调节基因表达,主要在转录后水平。在功能上,单个 miRNA 可以调节多个靶基因的表达。miRNAs 的研究正在迅速发展,最近的研究表明 miRNAs 在血管生物学和疾病中具有重要作用。许多 miRNA 在血管中高度表达,并且在病变血管中其表达失调。已经发现一些 miRNA 是血管病理学的关键调节剂,如动脉粥样硬化、脂蛋白代谢、炎症、动脉重塑、血管生成、平滑肌细胞再生、高血压、细胞凋亡、新生内膜增生和信号转导途径。因此,miRNAs 可能作为血管疾病的新型生物标志物和/或治疗靶点。本文总结了与 miRNAs 在血管系统中的疾病相关性和功能作用相关的当前研究,并讨论了 miRNAs 在血管疾病中的潜在应用。